drugset / Trial / NCT01759875

Effects of Gastric pH on the Pharmacokinetics of Atazanavir

NCT01759875

Phase 1 Completed 8 enrolled University of California, San Francisco
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this study is to evaluate the ability of a natural supplement (betaine hydrochloride) to affect the absorption of atazanavir in healthy volunteers. The investigators predict that betaine hydrochloride will increase the absorption of atazanavir in volunteers pre-treated with proton-pump inhibitors (PPIs).

Timeline

Start
2013-01
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atazanavir Other / unclassified 300 mg Oral
Subject Betaine Small molecule 1500 mg Oral
Subject Rabeprazole Small molecule 20 mg Oral
Comparator Ritonavir Other / unclassified 100 mg Oral

Indications

No indication recorded.